Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2023-04-26 00:00:00 ET · period of report 2023-03-14 · accession 0000895345-23-000254 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-26 | 2023-03-14 | CLOV | Martin Joseph Richards | GC | F - Tax | $0.93 | -283.1K | 2.82M | -9% | -$263.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-03-14 | F | D | 283,091 | $0.93 | 2,817,684 | D | — | — | (F1) Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting, on March 14, 2023, of 25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 15, 2022. The remaining RSUs vest in twelve equal quarterly installments beginning on the date that is three months after March 14, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date. |